Dr. Reddy`s Laboratories gains on entering into partnership with Apollo Hospitals
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Dr. Reddy's Laboratories is currently trading at Rs. 5271.15, up by 19.90 points or 0.38% from its previous closing of Rs. 5251.25 on the BSE.
The scrip opened at Rs. 5282.55 and has touched a high and low of Rs. 5305.00 and Rs. 5261.80 respectively. So far 31575 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 5514.65 on 21-Sep-2020 and a 52 week low of Rs. 3613.45 on 18-May-2020.
Last one week high and low of the scrip stood at Rs. 5398.00 and Rs. 5143.50 respectively. The current market cap of the company is Rs. 87662.37 crore.
The promoters holding in the company stood at 26.74%, while Institutions and Non-Institutions held 43.93% and 17.06% respectively.
Dr. Reddy's Laboratories and Apollo Hospitals have collaborated to initiate a COVID-19 vaccination programme with Sputnik V. The first phase of the programme will kick off with vaccinations in Hyderabad on May 17, 2021 and in Visakhapatnam on May 18, 2021 at Apollo facilities. The two entities were working to scale up the pilot and take the vaccine to other cities with an aim to inoculate as many Indians as possible.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
